Medication info
Loodil Suprap 160 mg (Fenofibrate)

Loodil Suprap 160 mg (Fenofibrate)

Prescription medicationTabletOral
Ingredient · strength
Fenofibrate›160mg / 1 tablet
Manufacturer / importer
Korea Hyutecs Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
100 tablets/box [10 tablets/PTP x 10], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201708083 · Approved 2017.11.27 · Insurance code 649103740

Summary

Main use
Treatment of primary hyperlipidemia (hypercholesterolemia, mixed dyslipidemia, etc.)
Who takes it
Adults · Children
Adult dose
○ Adults: Administer 160 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. Since this medicine may be less well absorbed on an empty stomach, administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients: Dose reduction is generally not necessary if renal function is not impaired. ○ Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine ≥ 2.5 mg/dL).
Child dose
○ Children: Clinical data on the use of this medicine in children are not yet available.

Ingredients

Manufacturer
Korea Hyutecs Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of primary hyperlipidemia (hypercholesterolemia, mixed dyslipidemia, etc.)

  • Primary dyslipidemia
  • hypercholesterolemia
  • hypertriglyceridemia
View approved original text

This medication is used to treat primary dyslipidemia, characterized by high cholesterol levels and elevated triglyceride levels occurring together. It helps regulate blood lipid levels and reduce the risk of cardiovascular diseases.

How to take

Adult dose

○ Adults: Administer 160 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. Since this medicine may be less well absorbed on an empty stomach, administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients: Dose reduction is generally not necessary if renal function is not impaired. ○ Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine ≥ 2.5 mg/dL).

Child dose

○ Children: Clinical data on the use of this medicine in children are not yet available.

Precautions

This drug should not be used in patients with liver dysfunction. Impaired liver function can lead to severe side effects due to interference with drug metabolism. Patients with moderate to severe renal impairment should also avoid this drug, as it poses a high risk of rhabdomyolysis due to muscle tissue damage. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug due to potential harm to the fetus or infant. Patients with allergies to this drug or its components should not use it, as allergic reactions can be severe. Patients with gallbladder disease or gallstones should exercise caution, as this drug may increase the likelihood of developing gallstones. Patients with a history of photosensitivity or phototoxic reactions related to this drug should avoid it. Severe reactions may occur with sun exposure or artificial ultraviolet light. This drug is not used in pediatric patients due to insufficient evidence of safety and efficacy. Patients with biliary cirrhosis or pancreatitis should also refrain from this medication, especially except in cases of acute pancreatitis due to severe hypertriglyceridemia. Patients with lactose intolerance or specific genetic metabolic disorders should not take this drug, as it contains lactose which may worsen symptoms. Patients with allergies to soybean oil, soy, or peanuts should be cautious due to potential allergic reactions from the ingredients in this drug. Patients with mild renal impairment must reduce the dose or extend the interval between doses to minimize the risk of rhabdomyolysis. Patients with liver dysfunction or past liver issues should regularly undergo liver function tests, and if abnormalities are found, dosage adjustment or discontinuation may be necessary. Patients with hypoalbuminemia, a history of gallstones, those on anticoagulants, those on HMG-CoA reductase inhibitors, the elderly, and individuals with lipid metabolic disorders should be administered this drug cautiously. This drug may affect the liver and biliary system, leading to elevated liver enzyme levels, hepatitis, gallstones, and cholestasis. Skin rashes, itching, and photosensitivity reactions may occur frequently and, rarely, hair loss may happen. Neurological symptoms such as dizziness, headaches, and fatigue can arise, and vascular abnormalities, such as thrombosis, may rarely occur. Muscle pain, muscle cramps, and elevated creatine kinase levels may occur, and consultation with a doctor is necessary if these symptoms arise; severe cases may require stopping the medication. Gastrointestinal symptoms, such as abdominal pain, nausea, vomiting, and diarrhea, may occur, and pancreatitis may occur rarely. Regular liver function tests and blood lipid level checks should be conducted during this drug therapy to monitor for abnormalities. This drug can interact with other medications, particularly when taken with anticoagulants, hypoglycemic agents, or cholesterol-lowering drugs, hence caution is required. Pregnant or nursing women should not take this drug, and women who may become pregnant must confirm their pregnancy status prior to use. The elderly may have reduced liver and kidney function, necessitating closer observation and care when taking this drug. No specific antidote exists for overdose, so strict adherence to the dosing regimen is required, and it should be stored out of reach of children.

Side effects

  • Elevated serum amino transferase levels
  • hepatomegaly
  • cholestatic hepatitis
  • gallstones
  • rash
  • itching
  • photosensitivity reactions
  • alopecia
  • malaise
  • hyperthermia
Show 42 more
  • dizziness
  • headache
  • peripheral neuropathy
  • thrombosis
  • elevated creatine kinase
  • myalgia
  • muscle cramps
  • arthralgia
  • rhabdomyolysis
  • urticaria
  • photoallergic dermatitis
  • gastrointestinal disorders
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • abdominal distension
  • pancreatitis
  • seizures
  • reduced hemoglobin
  • leukopenia
  • eosinophilia
  • elevated serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmias
  • fatigue
  • sexual dysfunction
  • weight gain
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • skin rash
  • anaphylaxis
  • angioedema
  • DRESS syndrome
  • exfoliative dermatitis
  • fever
  • systemic organ involvement
  • thrombocytopenia
  • agranulocytosis
  • myopathy
  • pulmonary embolism
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best stored at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

100 tablets/box [10 tablets/PTP x 10], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.